Volume 18, Number 10—October 2012
Dispatch
Orthobunyavirus Antibodies in Humans, Yucatan Peninsula, Mexico
Bradley J. Blitvich
, Rungrat Saiyasombat, Lourdes G. Talavera-Aguilar, Julian E. Garcia-Rejon, Jose A. Farfan-Ale, Carlos Machain-Williams, and Maria A. Loroño-Pino
, Rungrat Saiyasombat, Lourdes G. Talavera-Aguilar, Julian E. Garcia-Rejon, Jose A. Farfan-Ale, Carlos Machain-Williams, and Maria A. Loroño-PinoTable
Endpoint titers of serum samples collected from persons in Mexico and analyzed by using comparative PRNT*
| Patient ID no. |
Demographic characteristics
|
PRNT90 titers
|
Diagnosis | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Residence | Age, y/sex | CVV | CHLV | KRIV | SOURV | MAGV | WYOV | |||
| 28 | Yucatan | 18/M | 80 | 20 | – | – | 40 | – | UND | |
| 34 | Yucatan | 39/F | 80 | 20 | – | – | 20 | – | CVV | |
| 52 | Quintana Roo | 39/F | 160 | – | – | 40 | 80 | – | UND | |
| 54 | Yucatan | 32/M | 40 | 20 | – | – | 40 | – | UND | |
| 62 | Yucatan | 44/M | 40 | – | – | 20 | 20 | – | UND | |
| 72 | Yucatan | 23/M | 80 | – | – | – | 40 | – | UND | |
| 81 | Yucatan | 60/F | 20 | 20 | – | 20 | – | – | UND | |
| 92 | Yucatan | 13/M | 160 | 20 | – | 20 | 80 | – | UND | |
| 93 | Yucatan | 42/F | 40 | 20 | – | – | 20 | – | UND | |
| 113 | Yucatan | 24/F | 20 | – | – | – | – | – | UND | |
| 114 | Yucatan | 29/F | 40 | – | – | – | 20 | – | UND | |
| 120 | Yucatan | 60/F | 20 | – | – | 320 | – | – | SOURV or SOURV-like virus | |
| 159 | Yucatan | 54/M | 20 | – | – | – | 20 | – | UND | |
| 161 | Yucatan | 53/M | 20 | 20 | – | – | – | – | UND | |
| 163 | Yucatan | 27/F | 160 | 80 | 40 | – | 40 | – | UND | |
| 167 | Yucatan | 16/M | 160 | – | – | – | 40 | – | CVV | |
| 183 | Yucatan | 69/F | 20 | – | – | – | 20 | – | UND | |
| 184 | Yucatan | 34/M | 160 | 40 | – | – | 80 | – | UND | |
| 185 | Yucatan | 25/F | 20 | – | – | – | – | – | UND | |
| 192 | Campeche | 54/F | 80 | 40 | – | – | 20 | – | UND | |
| 193 | Yucatan | 16/F | 80 | – | – | – | 20 | – | CVV | |
| 194 | Yucatan | 69/F | 20 | – | – | 20 | – | – | UND | |
| 200 | Yucatan | 3/F | 40 | – | – | 40 | 40 | – | UND | |
| 205 | Yucatan | 53/M | 40 | – | – | 20 | 20 | – | UND | |
| 208 | Yucatan | 57/F | 20 | 160 | – | – | – | – | CHLV | |
| 210 | Yucatan | 42/M | 20 | – | – | – | 20 | – | UND | |
| 224 | Yucatan | 34/M | 20 | 20 | – | 20 | – | – | UND | |
| 234 | Yucatan | 39/F | 20 | 80 | – | – | 20 | – | CHLV | |
| 236 | Yucatan | 74/F | 20 | – | – | 20 | – | – | UND | |
| 386 | Yucatan | 14/F | 20 | – | – | 20 | – | – | UND | |
| 388 | Yucatan | 60/M | 160 | 1,280 | 160 | – | 40 | – | CHLV | |
| 389 | Yucatan | 5/M | 20 | – | – | 20 | – | – | UND | |
| 390 | Yucatan | 33/M | 40 | 20 | 40 | 20 | 40 | – | UND | |
| 392 | Yucatan | 22/M | 20 | – | – | – | – | – | UND | |
| 393 | Yucatan | 29/M | 40 | 20 | – | – | 40 | – | UND | |
| 396 | Yucatan | 34/F | 80 | – | – | – | 20 | – | CVV | |
| 397 | Yucatan | 32/M | 80 | – | – | – | 40 | – | UND | |
| 399 | Yucatan | 27/M | 320 | 1,280 | 160 | – | 320 | – | CHLV | |
| 400 | Yucatan | 37/F | 20 | – | – | – | – | – | UND | |
| 401 | Yucatan | 30/F | 160 | – | – | – | 40 | – | CVV | |
| 402 | Yucatan | 18/M | 20 | – | – | – | 20 | – | UND | |
| 403 | Yucatan | 50/F | 20 | 20 | – | – | – | – | UND | |
| 407 | Yucatan | 27/M | 80 | 20 | – | – | 40 | – | UND | |
| 408 | Yucatan | 40/F | 20 | – | – | – | – | – | UND | |
| 412 | Yucatan | 60/M | 20 | 320 | 80 | 40 | 40 | – | CHLV | |
| 415 | Yucatan | 17/F | 20 | – | – | 20 | – | – | UND | |
| 420 | Yucatan | 16/F | 160 | – | – | – | 20 | – | CVV | |
| 429 | Yucatan | 37/F | 20 | – | – | – | – | – | UND | |
| 442 | Yucatan | 10/F | 20 | 40 | – | 20 | – | – | UND | |
| 455 | Yucatan | 30/F | 20 | – | – | 20 | 20 | – | UND | |
*PRNT, plaque reduction neutralization test; CVV, Cache Valley virus; CHLV, Cholul virus; KRIV, Kairi virus; SOURV, South River virus; MAGV, Maguari virus, WYOV, Wyeomyia virus; –, titer <20; UND, undetermined orthobunyavirus.
